DURAMED PHARMACEUTICALS INC. – Trademark Portfolio
Entity Type: 03
DURAMED PHARMACEUTICALS INC. holds 76 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 70 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 13 trademarks are registered. Notable registered marks include DP, APRI, AVIANE, KARIVA, and PREFEST. The owner is based in WOODCLIFF LAKE, NJ.
400 CHESTNUT RIDGE ROAD
WOODCLIFF LAKE, NJ 07677
Showing of trademarks Trademarks
Trademark Classifications
DURAMED PHARMACEUTICALS INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does DURAMED PHARMACEUTICALS INC. have?
DURAMED PHARMACEUTICALS INC. has 76 U.S. trademarks filed with the USPTO. Of these, 13 registered, 41 abandoned, 22 cancelled.
What trademark classes does DURAMED PHARMACEUTICALS INC. file in?
DURAMED PHARMACEUTICALS INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are DURAMED PHARMACEUTICALS INC.'s most well-known trademarks?
DURAMED PHARMACEUTICALS INC.'s registered trademark portfolio includes well-known marks such as DP, APRI, AVIANE, KARIVA, and PREFEST. These are among 13 currently registered trademarks in the portfolio.
What is DURAMED PHARMACEUTICALS INC.'s trademark registration success rate?
DURAMED PHARMACEUTICALS INC. has a 17% trademark registration rate, with 13 out of 76 resolved applications resulting in successful registration. Currently, 0 applications are pending review.